APA (7th ed.) Citation

Robinson, H. R., Qi, J., Cook, E. M., Nichols, C., Dadashian, E. L., Underbayev, C., . . . Wiestner, A. (2018). A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood, 132(5), 521. https://doi.org/10.1182/blood-2018-02-830992

Chicago Style (17th ed.) Citation

Robinson, Hannah R., et al. "A CD19/CD3 Bispecific Antibody for Effective Immunotherapy of Chronic Lymphocytic Leukemia in the Ibrutinib Era." Blood 132, no. 5 (2018): 521. https://doi.org/10.1182/blood-2018-02-830992.

MLA (9th ed.) Citation

Robinson, Hannah R., et al. "A CD19/CD3 Bispecific Antibody for Effective Immunotherapy of Chronic Lymphocytic Leukemia in the Ibrutinib Era." Blood, vol. 132, no. 5, 2018, p. 521, https://doi.org/10.1182/blood-2018-02-830992.